NCAM-1

NCAM-1

NCAM-1 詳細

Molecule Name
Neural cell adhesion molecule 1
分子の別称
CD56,MSK39,NCAM1,N-CAM-1
Drug Development Progress
治験薬の数6
市販薬剤の数0
研究&開発段階Phase 2 Clinical
ターゲットの別称
Neural cell adhesion molecule 1,CD56,NCAM1,NCAM,Neural Cell Adhesion Molecule, NCAM,CD56 Antigen,N-CAM-1,MSK39,NCAM-1,Antigen Recognized By Monoclonal Antibody 5.1H11
バックグランド
NCAM1 belongs to the immunoglobulin superfamily of adhesion molecules. A wide range of alternatively spliced NCAM1 messenger RNAs (mRNAs) has been described to date, but only the 120-, 140-, and 180- kDa isoforms are commonly expressed. NCAM1 plays an important role in the regulation of neurogenesis, neurite outgrowth, proliferation, and cell migration, however, its function in hematopoiesis, including NK cells, is poorly understood. NCAM1 signaling is mediated either by homophilic or heterophilic interactions with fibroblast growth factor receptor (FGFR), L1-CAM, N-cadherin and other components of the extracellular matrix. Upon activation, NCAM1 triggers a variety of signaling cascades including FYN–focal adhesion kinase (FAK), MAPK, and phosphatidylinositol 3-kinase (PI3K) pathways.

NCAM-1 製品リスト

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
Lorvotuzumab mertansineBB-10901; IMGN-901; huN-901-DM1; IMGN-901-TAP; huN-901-SPP-DM1Phase 2 ClinicalImmunogen Inc
Carcinoma, Merkel Cell; Leukemia; Multiple Myeloma; Neuroblastoma; Neurofibrosarcoma; Ovarian Neoplasms; Pulmonary Blastoma; Rhabdomyosarcoma; Sarcoma, Synovial; Small Cell Lung Carcinoma; Wilms Tumor
詳細
EB-DART-NK01EB-DART-NK01Phase 2 ClinicalBeijing Biotech
Small Cell Lung Carcinoma
詳細
CUBT-906CUBT-906Phase 2 ClinicalCurative Biotechnology Inc
Glioblastoma
詳細
GD2/CD56 Bi-specific CAR-T Cell Therapy (Shenzhen Geno-Immune Medical Institute)bi-4SCAR GD2/CD56Phase 2 ClinicalShenzhen Geno-Immune Medical Institute
Neoplasms
詳細
IN-B015IN-B-015; IN-B00004Phase 1 ClinicalHK inno.N Corporation
Neoplasms
詳細
DXC-006DXC-006; DAC-006Phase 1 ClinicalHangzhou Dac Biotech Company Ltd
Hematologic Neoplasms; Lung Neoplasms; Solid tumours
詳細